Relatedly, syndecan 4 blocking antibodies inhibit the directional migration of B-cells in an asthma model, and B-cells from syndecan 4−/− mice also show impaired directional cell migration in an arthritis model (Endo et al., 2015; Polte et al., 2015). The gene discussed is SDC4; the disease is asthma.